Objective
Breast cancer (BC) is the most prevalent form of cancer in women. One in nine women will acquire BC at some point in their life and one in thirty will die from the disease . Most EU countries have adopted mass BC screening programmes as a way for detecting the disease early, using tools such as mammography machines. Mammography has been the medical industry’s “gold standard” breast cancer screening tool for nearly four decades. However, a number of adverse effects, backed up by mounting scientific evidence, are now limiting the use of mammography as a mass screening device.
MammoWave is a revolutionary BC screening device for highly accurate cancer detection based on safe microwaves instead of ionizing radiation (X-rays).
The excellent overall sensitivity (ongoing clinical trials show sensitivity above 90%), the simple method that requires no squishing of the breast, and the complete safety of the microwave imaging technique, make MammoWave primed for mass BC screening.
Fields of science
Programme(s)
Call for proposal
H2020-SMEInst-2018-2020-2
See other projects for this call
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
06081 Frazione Rivotorto
Italy